Metraipolis › archive › dc_cb7155d14e20
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial — Europe PMC PMID:40886716
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40886716
- DOI
- 10.1016/s1473-3099(25)00361-5
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T07:21:22.763Z
- SHA-256 of the archived text
d8bd4c6ae31893e1afdde9a6160c56d2e9ae431382b5708b7ffc4c77d27d336c- Stable URL of this page
https://metraipolis.com/documento/dc_cb7155d14e20
How to cite
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial — Europe PMC PMID:40886716 — Europe PMC (en), https://europepmc.org/article/MED/40886716 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb7155d14e20 (Metraipolis archive dc_cb7155d14e20, sha256 d8bd4c6ae31893e1afdde9a6160c56d2e9ae431382b5708b7ffc4c77d27d336c)
BibTeX
@misc{dccb7155d14e20,
title = {Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial — Europe PMC PMID:40886716},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40886716},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb7155d14e20; sha256 d8bd4c6ae31893e1afdde9a6160c56d2e9ae431382b5708b7ffc4c77d27d336c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40886716. Agents can read the archived copy with the MCP tool read_document.